{"agranulocytosis": 2.67, "anaphylactic reaction": 2.09, "autoimmune haemolytic anaemia": 20.36, "bronchospasm": 5.4, "dermatomyositis": 67.95, "drug effective for unapproved indication": 39.28, "erythema": 2.45, "flushing": 2.58, "haemolytic anaemia": 6.72, "hypersensitivity": 3.39, "hypotension": 3.12, "hypoxia": 8.77, "immune thrombocytopenia": 36.11, "infusion related reaction": 29.56, "insurance issue": 43.23, "intentional dose omission": 19.64, "intentional product use issue": 4.98, "mantle cell lymphoma": 604.44, "multiple sclerosis": 16.58, "nephrotic syndrome": 13.94, "neuromyelitis optica spectrum disorder": 119.68, "neutropenia": 2.24, "off label use": 17.58, "oropharyngeal discomfort": 5.45, "oxygen saturation decreased": 5.14, "pneumonitis": 4.05, "polymyositis": 68.82, "product substitution issue": 15.02, "pruritus": 2.27, "rash maculo-papular": 2.08, "serum sickness": 33.22, "systemic lupus erythematosus": 13.17, "throat irritation": 9.32, "throat tightness": 6.28, "thrombocytopenia": 2.11, "underdose": 8.59, "urticaria": 2.2, "vasculitis": 4.98, "waldenstrom's macroglobulinaemia": 233.51}